Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis
Yasunori Omata(The University of Tokyo), Sakae Tanaka(University of Tokyo Hospital), Takeshi Miyamoto(Kumamoto Health Science University), Takuma Koyama(Tokyo Women's Medical University), Tetsuro Yasui(Teikyo University), Yuuki Imai(Ehime University), Chikao Morimoto(Juntendo University), Sachiko Seo(National Cancer Center Hospital East), Yuho Kadono(The University of Tokyo), Naohiro Izawa(The University of Tokyo), Jun Hirose(Kumamoto University Hospital), Mineo Kurokawa(University of Tokyo Hospital), Shuichi Tsutsumi(The University of Tokyo), Hiroyuki Aburatani(The University of Tokyo), Shinya Nakamura(The University of Tokyo), Takumi Matsumoto(The University of Tokyo)
Cited by 11
Related Papers
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694